Time to progression by MRD. (A) Time-to-progression by flow cytometry (Flow) minimal residual disease (MRD) status for patients achieving a complete response (n = 82 evaluable). (B) Time-to-progression by polymerase chain reaction (PCR) MRD status for patients achieving a complete response (n = 66 evaluable).